September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
August 12, 2022
The University of Cincinnati's Alberto Espay, MD, joined WVXU's Cincinnati Edition to discuss recent allegations that a key 2006 Alzheimer's study from the University of Minnesota may have been fabricated.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
June 15, 2022
The University of Cincinnati's Paul Crosby, MD, was a guest on Local 12's What's Happening in Health program to discuss the ongoing mental health crisis and the Lindner Center of HOPE's new campaign to expand services.
June 3, 2022
The University of Cincinnati's Jensine' Clark and Emily Nurre lead transition clinics that help guide patients with childhood-onset disabilities and epilepsy from pediatric to adult care.
June 10, 2022
Healio highlighted clinical trial data presented by University of Cincinnati professor and Cincinnati Children's Hospital Medical Center oncologist Robin Norris on a new combination treatment for young patients with advanced-stage Hodgkin lymphoma.
October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
September 9, 2022
University of Cincinnati stroke expert Pooja Khatri, MD, was featured in a WESA article providing insights on stroke recovery in light of Pennsylvania Senate candidate John Fetterman campaigning while recovering from a stroke.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.